Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.62 |
| ▸ | OPRD1 | P41143 | 6/20 | 0.58 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.58 |
| ▸ | NPY1R | P25929 | 1/20 | 0.56 |
| ▸ | NPY2R | P49146 | 1/20 | 0.56 |
| ▸ | NPY4R | P50391 | 1/20 | 0.56 |
| ▸ | LTA4H | P09960 | 1/20 | 0.55 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.52 |
| ▸ | ACE | P12821 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3059716 | 1.00 | FOLH1 (0.62) | FOLH1OPRD1OPRM1NPY1RNPY2R | |
| Methane SCHEMBL29403415 | 0.99 | FOLH1 (0.60) | FOLH1OPRD1OPRM1NPY1RNPY2R | |
| SCHEMBL29689931 | 0.99 | FOLH1 (0.60) | FOLH1OPRD1OPRM1NPY1RNPY2R | |
| SCHEMBL30578468 | 0.98 | FOLH1 (0.62) | FOLH1OPRD1OPRM1NPY1RNPY2R | |
| SCHEMBL31558391 | 0.94 | OPRD1 (0.66) | FOLH1OPRD1OPRM1NPY1RNPY2R | |
| SCHEMBL30683246 | 0.94 | FOLH1 (0.66) | FOLH1OPRD1OPRM1NPY1RNPY2R | |
| SCHEMBL29477112 | 0.94 | FOLH1 (0.66) | FOLH1OPRD1OPRM1NPY1RNPY2R | |
| SCHEMBL29531738 | 0.94 | FOLH1 (0.66) | FOLH1OPRD1OPRM1NPY1RNPY2R | |
| SCHEMBL29532240 | 0.94 | FOLH1 (0.69) | FOLH1OPRD1NPY1RNPY2RNPY4R | |
| SCHEMBL14940816 | 0.94 | FOLH1 (0.69) | FOLH1OPRD1NPY1RNPY2RNPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110560015-A | nano hydrated oxidized metal composite hydrogel and application of nano hydrated oxidized metal composite hydrogel in sewage treatment | 魏旭榕 | 2019-12-13 | — | — | CN | claimed |
| CN-110560015-A | nano hydrated oxidized metal composite hydrogel and application of nano hydrated oxidized metal composite hydrogel in sewage treatment | 魏旭榕 | 2019-12-13 | — | — | CN | disclosed |
| CN-108840907-A | Tyroserleutide-Phephorbide a monoesters and preparation method thereof | 桂林市兴达光电医疗器械有限公司 | 2018-11-20 | — | — | CN | disclosed |
| CN-108771759-A | Tyroserleutide-chlorin e 6 metal complex ester and preparation method thereof | 桂林市兴达光电医疗器械有限公司 | 2018-11-09 | — | — | CN | disclosed |
| CN-108707183-A | Tyroserleutide-chlorin e 6 monoesters and preparation method thereof | 桂林市兴达光电医疗器械有限公司 | 2018-10-26 | — | — | CN | disclosed |
| CN-103910738-B | A kind of Bisbenzylisoquinolincompounds quaternary ammonium salt and preparation method thereof and the application in preparing antitumor drug | 山东师范大学 | 2016-07-06 | — | — | CN | disclosed |
| CN-103910740-B | Tetrandrine derivant and preparation method thereof and the application in prepared by antitumor drug | 山东师范大学 | 2016-07-06 | — | — | CN | disclosed |
| CN-103910741-B | Bisbenzylisoquinolincompounds trimethyl-glycine and preparation method thereof and the application in antitumor drug preparation | Shangdong Normal University (CN) | 2016-04-13 | — | — | CN | disclosed |
| CN-104114537-A | Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection | ASTEX THERAPEUTICS LTD | 2014-10-22 | — | — | CN | disclosed |
| CN-104039766-A | Pharmaceutical compounds | ASTEX THERAPEUTICS LTD | 2014-09-10 | — | — | CN | disclosed |
| CN-103923092-A | Tetrandrine derivatives and preparation method and application thereof in preparation of antitumor medicine | UNIV SHANDONG NORMAL | 2014-07-16 | — | — | CN | disclosed |
| CN-103910741-A | Bisbenzylisoquinoline betaine as well as preparation method thereof and application thereof in preparation of anti-tumor medicament | UNIV SHANDONG NORMAL | 2014-07-09 | — | — | CN | disclosed |
| CN-103910739-A | Bisbenzylisoquinoline glycine betaines as well as preparation method and application thereof in preparing anti-tumor medicines | UNIV SHANDONG NORMAL | 2014-07-09 | — | — | CN | disclosed |
| CN-103910738-A | Bisbenzylisoquinoline quaternary ammonium salt as well as preparation method and application thereof in preparing antitumor drug | UNIV SHANDONG NORMAL | 2014-07-09 | — | — | CN | disclosed |
| CN-103910740-A | Tetrandrine derivatives and preparation method thereof, and application of tetrandrine derivatives in preparing anti-tumor medicines | UNIV SHANDONG NORMAL | 2014-07-09 | — | — | CN | disclosed |
| US-7696152-B2 | Biologically active peptide consisting of tyrosyl-seryl-leucine (YSL) | CMS Peptides Patent Holdings Company Limited (VG) | 2010-04-13 | — | — | US | disclosed |
| US-7696152-B2 | Biologically active peptide consisting of tyrosyl-seryl-leucine (YSL) | CMS Peptides Patent Holdings Company Limited (VG) | 2010-04-13 | — | — | US | disclosed |
| CN-100457922-C | Method for detecting anti-liver cancer efficacy of tyroserleutide, kit and gene chip used thereby | KANGZHE MEDICAL RES SHENZHEN C (CN) | 2009-02-04 | — | — | CN | disclosed |
| CN-1837374-A | Method for detecting anti-liver cancer efficacy of tyroserleutide, kit and gene chip used thereby | YITAI MEDICAL RES SHENZHEN CO (CN) | 2006-09-27 | — | — | CN | disclosed |